Fuse Oncology Congratulates Dr. Chris Jahraus on Being Named a 2025 ASTRO Fellow

Fuse Oncology is proud to celebrate one of our Clinical Liaison Council members, Dr. Chris Jahraus, on being named a 2025 Fellow of the American Society for Radiation Oncology. This prestigious honor is a testament to Dr. Jahraus’s exceptional contributions to the field of radiation oncology and his commitment to advancing patient care.

The FASTRO designation recognizes ASTRO members for outstanding achievements in cancer research, education, clinical care, and service to the specialty. This year, ASTRO selected just 43 members to join the ranks of Fellows, a distinction awarded to only 541 of its 10,000 members worldwide since the program’s inception in 2006.

The 2025 ASTRO Fellows include physicians, physicists, and cancer biologists whose work continues to expand the role of radiation therapy in cancer treatment. Dr. Jahraus’s recognition reflects his dedication to excellence, innovation, and improving the lives of patients; values that resonate deeply with our mission at Fuse.

He will be formally recognized at ASTRO’s 67th Annual Meeting in San Francisco on Tuesday, September 30. Please join us in congratulating Dr. Jahraus on this well-deserved honor.